Showing results (11-20 of 190) with videos related to
Sort By:
Pageof 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2023
PD-1 Monotherapy Reigns Supreme in Adjuvant Melanoma…But for How Long?Ryan C Augustin, Jason J LukeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2020
Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment ResponseChristopher S Garris, Jason J LukeOncotarget|February 17, 2015
PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanomaJason J Luke, Patrick A OttCancer|December 24, 2019
Considering adjuvant therapy for stage II melanomaAndrew S Poklepovic, Jason J LukeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2023
Myeloid Maturity: ATRA to Enhance Anti-PD-1?Daniel J Olson, Jason J LukePharmacological Research|March 22, 2017
Mechanistic and pharmacologic insights on immune checkpoint inhibitorsRandy F Sweis, Jason J LukeSeminars in Oncology|April 10, 2012
Advances in the systemic treatment of cutaneous sarcomasJason J Luke, Mary Louise KeohanFuture Oncology (London, England)|May 11, 2022
A plain language summary from pembrolizumab plus ipilimumab following PD-1 antibody failure in melanomaDaniel J Olson, Jason J LukeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2023
CD16+ Macrophages: An Emerging Biomarker for Combined CTLA-4 and PD-1 BlockadeJames W Smithy, Jason J LukeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2024
NETosis Impact on Tumor Biology, Radiation, and Systemic Therapy ResistanceYvonne M Mowery, Jason J LukePageof 19